Top Franklin Templeton Funds

Franklin Biotechnology Discovery A (FBDIX) seeks capital appreciation by primarily investing in securities of biotechnology companies and discovery research firms.

This non-diversified fund may invest a substantial portion of assets in equity securities of smaller capitalization companies with a market capitalization of less than $1.5 billion.

Gilead Sciences Inc. (GILD - Analyst Report), Celgene Corp. (CELG - Analyst Report) and Genzyme Corp. (GENZ - Analyst Report) are among the fund’s key holdings.

Templeton Developing Markets A (TEDMX) seeks long-term capital appreciation through investment in securities of emerging economies.

The fund may invest up to 20% of net assets in the securities of issuers in developed market countries. It may also invest in exchange-traded funds to gain exposure to certain segments of the equity markets while maintaining liquidity.

J. Mark Mobius has been lead manager at the fund since October 1991. The fund distributes dividends and capital gains, if any, annually.

Click here to see all the mutual funds offered by Franklin Templeton.